A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2001
10/18/2001	WO2001038352A3 Methods of inhibiting metastasis
10/18/2001	WO2001036626A3 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
10/18/2001	WO2001036455A3 Chlamydia antigens and corresponding dna fragments and uses thereof
10/18/2001	WO2001031015A3 36p6d5: secreted tumor antigen
10/18/2001	WO2001026683A3 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses
10/18/2001	WO2001026608A3 Dna vaccines encoding antigen linked to a domain that binds cd40
10/18/2001	WO2001025213B1 Pyrrolo imidazole derivatives and their use as medicaments
10/18/2001	WO2001023540A3 P-glycoproteins and uses thereof
10/18/2001	WO2001021201A3 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen
10/18/2001	WO2001021199B1 Highly efficient dendritic cell-targeted dna-vaccination
10/18/2001	WO2000069898A8 Molecular interactions in allergy cells
10/18/2001	WO2000057837A9 Compositions and methods for effecting the levels of cholesterol
10/18/2001	WO2000040270A3 Methods of prolonging transplant survival using immunotoxins and costimulation blockade of cd154 and cd28
10/18/2001	WO2000039301A9 Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
10/18/2001	WO2000039283A9 Use of cd40 engagement to alter t cell receptor usage
10/18/2001	WO2000020041A9 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
10/18/2001	US20010031779 Methods and materials for treating and preventing inflammation of mucosal tissue
10/18/2001	US20010031268 Neisseria culture
10/18/2001	US20010031267 Method for treatment of canine distemper
10/18/2001	US20010031266 Mixture of a sialic acid binding compound and antigens
10/18/2001	US20010031264 Administering a nucleic acids
10/18/2001	US20010031262 Synthetic polymeric carrier; antiallergens
10/18/2001	US20010031261 Use of genetically engineered antibodies to treat multiple myeloma
10/18/2001	US20010031260 Administering tumor necrosis factor antagonist; rheumatic diseases, skin disorders
10/18/2001	US20010031256 Vision defects
10/18/2001	US20010031253 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
10/18/2001	US20010031252 Endogenous immune response
10/18/2001	DE10115276A1 Preparation of vaccine against Salmonella, useful for protecting poultry, by inactivating enterotoxins and cytotoxins from the serovar 'Weltevreden'
10/18/2001	DE10016877A1 (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung (Glyco) proteins with high immunoreactivity, and a method for their preparation
10/18/2001	CA2406033A1 Anti-d monoclonal antibodies
10/18/2001	CA2405912A1 Albumin fusion proteins
10/18/2001	CA2405806A1 A method to prevent graft rejection using tgf-.beta. to induce t suppressor cells
10/18/2001	CA2405800A1 Novel secreted protein
10/18/2001	CA2405476A1 Compounds and methods for modulating endothelial cell adhesion
10/18/2001	CA2405181A1 Human pyruvate dehydrogenese phosphatase
10/18/2001	CA2405151A1 Bile acid containing prodrugs with enhanced bioavailability
10/18/2001	CA2405052A1 Chlamydial glycolipid vaccines
10/18/2001	CA2404988A1 Listeria monocytogenes genome, polypeptides and uses
10/18/2001	CA2403425A1 Multivalent antibodies and uses therefor
10/18/2001	CA2401836A1 Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
10/17/2001	EP1146125A1 Poxvirus with targeted infection specificity
10/17/2001	EP1146056A1 Antibodies which activate an erythropoietin receptor
10/17/2001	EP1145011A2 Compositions and methods for the diagnosis and treatment of tumor
10/17/2001	EP1144998A2 Neisseria genomic sequences and methods of their use
10/17/2001	EP1144678A2 Susceptibility to psoriasis
10/17/2001	EP1144654A2 Serine protease
10/17/2001	EP1144651A1 Polypeptides derived from jnk3
10/17/2001	EP1144650A2 Goodpasture antigen binding protein
10/17/2001	EP1144646A2 Mutant hepatitis b surface antigen and testing
10/17/2001	EP1144645A1 Neisseria meningitidis polypeptide basb052
10/17/2001	EP1144644A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
10/17/2001	EP1144643A1 Neisseria meningitidis antigen
10/17/2001	EP1144642A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/17/2001	EP1144640A2 Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001	EP1144638A2 Chlamydia antigens and corresponding dna fragments and uses thereof
10/17/2001	EP1144634A2 Novel complex-forming proteins
10/17/2001	EP1144633A1 Polypeptide
10/17/2001	EP1144632A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/17/2001	EP1144631A2 Insulin-synthesis genes
10/17/2001	EP1144628A2 Human vanilloid receptor gene
10/17/2001	EP1144626A2 Methods of monitoring hiv drug resistance
10/17/2001	EP1144602A1 Peptides and proteins for desensitizing subjects allergic to bee venom and compositions containing same
10/17/2001	EP1144600A2 Akt-3 nucleic acids, polypeptides, and uses thereof
10/17/2001	EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001	EP1144590A1 Compartmentalization of recombinant polypeptides in host cells
10/17/2001	EP1144453A1 Anti-ccr4 antibodies and methods of use therefor
10/17/2001	EP1144451A2 Method of modulating cell differentiation or neoplastic trnasformation by altering cadherin-11 expression or function
10/17/2001	EP1144450A1 Mammalian alpha-helical protein - 12
10/17/2001	EP1144448A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
10/17/2001	EP1144442A2 Streptococcal alpha2m-binding protein
10/17/2001	EP1144014A2 Composition and method for obtaining specific immunisation against one or more antigens using different recombinant vectors
10/17/2001	EP1144010A2 Methods of prolonging transplant survival using immunotoxins and costimulation blockade of cd154 and cd28
10/17/2001	EP1144008A1 Modulation of systemic memory t cell trafficking
10/17/2001	EP1144006A2 Synergistic inhibition of hiv-1 fusion and attachment, compositions and antibodies thereto
10/17/2001	EP1144005A1 Treatment of papillomavirus infections
10/17/2001	EP1144004A1 Her-2 binding antagonists
10/17/2001	EP1144001A2 Inactivated influenza virus vaccine for nasal or oral administration
10/17/2001	EP1143997A1 Tumor necrosis factor antagonists and their use in endometriosis
10/17/2001	EP1143993A1 Method of suppressing ongoing acute allograff rejection
10/17/2001	EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001	EP1143987A1 Natural composition and method for the treatment of sexual dysfunction
10/17/2001	EP1143984A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
10/17/2001	EP1143982A2 Method for preparing membrane vesicles
10/17/2001	EP1143934A1 Genetic immunization with co-delivery of nucleic acid and cytokines
10/17/2001	EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers
10/17/2001	EP1143931A1 Pulmonary drug delivery
10/17/2001	EP0672120B1 Production of human monoclonal antibodies active against hepatitis b surface antigen
10/17/2001	EP0633784B2 Hepatitis vaccins containing 3-0 deacylated monophosphoryl lipid A
10/17/2001	CN1318105A Methods for down-regulating osteoprotegerin ligand activity
10/17/2001	CN1318103A Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001	CN1317976A Multicomponent vaccines
10/17/2001	CN1317975A Method of using zot or zonulin to inhibit lymphocyte proliferation in antigen-specific manner
10/17/2001	CN1317973A Prepns. for immunotherapy for cancer having bacterial somatic constituent as active ingredient
10/17/2001	CN1317952A Improved method for targeted topial treatment of disease
10/17/2001	CN1317571A Method for constituting genetically engineered cell strain and bacterial strain for vaccine of hepatitis B
10/17/2001	CN1317569A Method for preparing mammal cell kinetin synthetic inhibitory factor
10/17/2001	CN1317343A Pharmaceutical Application of mammal cell kinetin synthetic inhibitory factor
10/17/2001	CN1073158C Anti-egfr single-chain Fvs and anti-egfr antibodies
10/17/2001	CN1073118C Diagnostics virus of hepatitis C
10/17/2001	CN1073115C WS7622A mono-or di-sulfate process for prepn. thereof

1 ... 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 ... 1823